Featured News

9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment.

For the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.

The Celiac Disease Foundation recently published an article in Mediaplanet’s Autoimmune Diseases digital campaign.

The Celiac Disease Foundation is proud to have been involved by recruiting patients essential for this trial’s success.

The NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.

Anokion SA announced that they have initiated patient dosing in the multiple ascending dose (MAD) portion of its ACeD study.

The ACeD Study is looking for volunteers with celiac disease to participate in a phase 1 clinical trial testing the investigational drug KAN-101.

The Celiac Disease in Learning Environments: A Continuing Education Program for Nurses Who Care for Children with Celiac Disease training seminar will complement the recommendations found in the 2020 Voluntary Recommendations for Managing Celiac Disease in Learning Environments.

Registration is open for Virtual Camp Celiac 2021 for children ages 9-17 years old, diagnosed with celiac disease requiring a lifelong strict gluten-free diet.

The Celiac Disease Genomic Environmental Microbiome and Metabolomic (CDGEMM) study is revealing how genetic and lifestyle factors make children susceptible to autoimmune diseases such as celiac disease, inflammatory bowel disease, and multiple sclerosis.